Department of Cardiac Surgery, 27178University Hospital Heidelberg, Heidelberg, Germany.
Department of Pediatric Cardiology, 27178University Hospital Heidelberg, Heidelberg, Germany.
World J Pediatr Congenit Heart Surg. 2022 Jul;13(4):426-435. doi: 10.1177/21501351221099933.
Neonatal coarctation of the aorta (CoA) is primarily treated by surgical repair. However, under certain high-risk constellations, initial stent angioplasty may be considered followed by surgical repair. We report our experience with this staged approach. All patients undergoing surgical CoA repair following prior stenting at our institution between January 2011 and December 2019 were included in this retrospective analysis. The patients were classified to be at high risk because of cardiogenic shock, associated complex cardiac malformations, neonatal infection, necrotizing enterocolitis, and extracardiac conditions, respectively. Outcomes were analyzed and compared with neonates who underwent surgical CoA repair without prior stenting in the same observation period.
Twenty-six neonates received stent implantation at a median age of 20 days (IQR 9-33 days). Subsequent surgical repair was conducted at an age of 4.2 months (IQR 3.2-6.1 months) with a median body weight of 5.6 kg (IQR 4.5-6.5 kg). Cardiopulmonary bypass was applied in 96% of cases. Extended end-to-end anastomosis was possible in 11 patients. Extended reconstruction with patch material was necessary in the remaining patients. One fatality (3.8%) occurred 33 days postoperatively. At a median follow-up of 5.2 years after initial stenting, all remaining patients were alive; 15/25 patients (60%) were free from re-intervention. Of note, re-intervention rates were comparable in neonates (n = 76) who were operated on with native CoA (28/74 patients; 38%; = .67).
Neonatal stent angioplasty for CoA results in increased complexity of the subsequent surgical repair. Nevertheless, this staged approach allows to bridge high-risk neonates to later surgical repair with reduced perioperative risk and acceptable midterm outcomes.
新生儿主动脉缩窄(CoA)主要通过手术修复治疗。然而,在某些高危情况下,可能会考虑初始支架血管成形术,随后再进行手术修复。我们报告了这种分阶段方法的经验。
本回顾性分析纳入了 2011 年 1 月至 2019 年 12 月期间,在我院接受过先前支架置入术、随后行外科 CoA 修复的所有患者。这些患者被归类为高危患者,分别因为心源性休克、合并复杂心脏畸形、新生儿感染、坏死性小肠结肠炎和心脏外疾病。分析了这些患者的结果,并与同一观察期内未接受过支架置入术的新生儿外科 CoA 修复结果进行了比较。
26 例新生儿在中位年龄 20 天(IQR 9-33 天)时接受支架植入。随后在中位年龄 4.2 个月(IQR 3.2-6.1 个月)时进行外科修复,中位体重为 5.6kg(IQR 4.5-6.5kg)。96%的病例应用体外循环。11 例患者可施行体外循环。其余患者需要用补片材料进行延长重建。1 例患者术后 33 天死亡(3.8%)。在初次支架置入后中位随访 5.2 年时,所有存活患者(n=25);15/25 例患者(60%)无需再次介入。值得注意的是,有 native CoA 的新生儿(n=76)的再干预率也相当(28/74 例患者;38%; = .67)。
新生儿 CoA 的支架血管成形术会增加后续手术修复的复杂性。然而,这种分阶段方法可以降低围手术期风险,使高危新生儿安全过渡到后期手术修复,并获得可接受的中期结果。